[FATE] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 17.06%
YoY- -26.22%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 44,356 14,981 18,549 18,414 17,067 14,225 13,412 121.49%
PBT -56,363 -83,563 -76,105 -65,690 -68,621 -43,308 -55,133 1.47%
Tax -8,056 -2,828 -757 -8,777 -2,206 -11,315 8,354 -
NP -48,307 -80,735 -76,105 -56,913 -68,621 -43,308 -55,133 -8.41%
Tax Rate - - - - - - - -
Total Cost 92,663 95,716 94,654 75,327 85,688 57,533 68,545 22.19%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -108.91 -538.92 -410.29 -309.07 -402.07 -304.45 -411.07 -58.64%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.50 -0.83 -0.79 -0.59 -0.72 -0.45 -0.58 -9.39%
EPS Diluted -0.50 -0.83 -0.79 -0.59 -0.72 -0.45 -0.58 -9.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.